IL-12 based gene therapy in veterinary medicine

Darja Pavlin1, Maja Cemazar, Gregor Sersa

  • 1University of Ljubljana, Veterinary Faculty, Small Animal Clinic, Cesta v Mestni log 47, Ljubljana, 1000, Slovenia.

Summary

Interleukin-12 (IL-12) gene therapy shows significant antitumor effects in large animal models, offering a promising bridge for human cancer treatments. This approach is safe and well-tolerated, paving the way for veterinary and human clinical trials.